To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Generation Bio debuts IPO
Cambridge, Massachusetts-based Generation Bio, a genetic medicines company, has raised about $200 million for its IPO after pricing its over 10.5 million shares at $19 per share.
